Login / Signup

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).

Stephanie KornKatrin MilgerDirk SkowaschChristian SchulzCordula MohrlangMartin WernitzThomas PaulssonMichael HennigRoland Buhl
Published in: Journal of asthma and allergy (2023)
The GAN registry data confirm the effectiveness of mepolizumab in a real-world setting. Treatment benefits are maintained over time. While the asthma of patients treated in routine practice was more severe, the results observed with mepolizumab are broadly consistent with RCTs.
Keyphrases